Mink Therapeutics, INC. (INKT) SEC Filings — 2024
20 SEC filings for Mink Therapeutics, INC. (INKT) in 2024.
Filings
- MiNK Therapeutics Files Definitive Proxy Statement — DEF 14A · Dec 20, 2024
- MiNK Therapeutics Files 8-K on Financials — 8-K · Nov 14, 2024
- MiNK Therapeutics Reports Q3 2024 Equity Changes, Agenus Agreement — 10-Q · Nov 14, 2024
- MiNK Therapeutics Appoints New Chief Medical Officer — 8-K · Oct 31, 2024
- MiNK Therapeutics Appoints New CMO, Elects Director — 8-K · Oct 18, 2024
- MiNK Therapeutics Faces Delisting Concerns — 8-K · Sep 13, 2024
- MiNK Therapeutics Faces Nasdaq Delisting Warning — 8-K · Aug 30, 2024
- MiNK Therapeutics Files 8-K on Operations and Financials — 8-K · Aug 13, 2024
- MiNK Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- MiNK Therapeutics Files 8-K on Shareholder Votes — 8-K · Jun 17, 2024
- Mink Therapeutics, INC. SC 13G Filing — SC 13G · May 22, 2024
- MiNK Therapeutics Files 8-K for Equity Sale — 8-K · May 16, 2024
- MiNK Therapeutics Files 8-K on Financials — 8-K · May 14, 2024
- MiNK Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- MiNK Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- MiNK Therapeutics Files 8-K on Financials — 8-K · Mar 21, 2024
- MiNK Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- MiNK Therapeutics Faces Nasdaq Delisting Warning — 8-K · Feb 29, 2024
- Insider Garo Armen Files SC 13D for MiNK Therapeutics — SC 13D · Feb 14, 2024
- MiNK Therapeutics Reports New Material Agreement & Financial Obligation — 8-K · Feb 14, 2024